Despite rumours about Venom and Knull taking centre stage in Spider-Man 4, there are still plenty of other supervillains from ...
The PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial is 100% enrolled; expect to report topline data for this cohort in late Q1 2025 or Q2 2025Approximately $264 million in cash, cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback